In glioma, mutations and epigenetic changes such as isocitrate dehydrogenase (IDH) mutations, chromosome 1p/19q co-deletion, and O6-methylguanine–DNA methyltransferase (MGMT) hypermethylation have demonstrated clinical importance. The gene discussed is MGMT; the disease is glioma.